Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Return on Capital Employed (2021 - 2025)

Rapid Micro Biosystems' Return on Capital Employed history spans 5 years, with the latest figure at 77.51% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 1839.0% to 77.51% in Q4 2025 year-over-year; TTM through Dec 2025 was 77.51%, a 1839.0% decrease, with the full-year FY2025 number at 69.67%, down 2132.0% from a year prior.
  • Return on Capital Employed hit 77.51% in Q4 2025 for Rapid Micro Biosystems, down from 71.57% in the prior quarter.
  • Over the last five years, Return on Capital Employed for RPID hit a ceiling of 20.57% in Q4 2021 and a floor of 77.51% in Q4 2025.
  • Historically, Return on Capital Employed has averaged 45.76% across 5 years, with a median of 44.15% in 2023.
  • Biggest five-year swings in Return on Capital Employed: plummeted -688bps in 2022 and later plummeted -2057bps in 2025.
  • Tracing RPID's Return on Capital Employed over 5 years: stood at 20.57% in 2021, then tumbled by -73bps to 35.67% in 2022, then fell by -24bps to 44.25% in 2023, then plummeted by -34bps to 59.12% in 2024, then crashed by -31bps to 77.51% in 2025.
  • Business Quant data shows Return on Capital Employed for RPID at 77.51% in Q4 2025, 71.57% in Q3 2025, and 71.88% in Q2 2025.